MEPIRAPIM is an analogue of the indole-based cannabinoid JWH-018, which differs from the 4-methylpiperazine group in the naphthyl group and has been used in synthetic cannabis products as an active ingredient. Together with FUBIMINA, it was first recognized in Japan in 2013.